LITSLite Strategy

Crypto · Financial Services · Nasdaq

Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company that has historically developed novel and differentiated cancer therapies. 10-K, Item 1

Headquarters: San Diego, CA
CEO: Justin J. File
Next results: around Feb 16, 2027

Compare with peers → Embed

Every trade in LITS shares that directors, officers and 10% owners reported on Form 4 since May 14, 2026. Open-market buys and sales are the trades the insider chose to make; grants, option exercises and shares withheld for tax are part of pay.

Bought on the market $21K 1 trade by 1 insider

Sold on the market $0 0 trades by 0 insiders

All Buys and sales Buys Sales

Date	Insider	Role	Type	Shares	Price	Value	Owned after
Jun 24, 2026	James P. Flynn	Director	Buy	25,000	0.86	21K	125,000

From the Form 4s in SEC's filing index; each date links to the filing. The Insider selling plans tab shows planned sales (10b5-1 plans and Form 144).

Work on LITS in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/LITS/export.csv") into a cell.